Examinations of OMT effective for prevention of MACE of the subjects with CAD and/or PAD in Japan. (Exo-MACE in Japan)

Examinations of OMT effective for prevention of MACE of the subjects with CAD and/or PAD in Japan. (Exo-MACE in Japan) - Exo-MACE in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035665

Enrollment

300

Registered

2019-02-01

Start date

2012-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects with CAD orand PAD who admitted in Yokohama City University Hospital from November 1, 2012 to June 30, 2015 are randomly assigned to the study with informed consent for clinical study (B150301009).

Interventions

Optimal Medical Treatment non Optimal Medical Treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects with CAD or/and PAD who admitted in Yokohama City University Hospital from November 1, 2012 to June 30, 2015 are randomly assigned to the study with informed consent for clinical study (B150301009).The subjects who admitted in Yokohama City University Hospital and are over 20 years old.

Exclusion criteria

Exclusion criteria: The subjects who the attending physicians decide inappropriately.

Design outcomes

Primary

Measure	Time frame
MACE (cardiovascular death, limb amputation, non-fetal myocardial infarction, non-fetal acute coronary syndrome, non-fetal congestive heart failure, non-fetal stroke, and re-vascularization)	—

Countries

Japan

Contacts

Public ContactSae Teranaka

Yokohama City University Graduate School of Medicine, University Hospital Department of Cardiology

tommmish@yokohama-cu.ac.jp+81-45-787-2635

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026